Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)

INTRODUCTION: Second-generation basal insulin analogues have been shown to reduce hypoglycemia in several trials and observational studies of select populations; however, it remains unclear whether these results persist in real-world settings. Using self-reported hypoglycemia events, we assessed whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Jason E., Harris, Stewart B., Ryan, Bridget L., Zou, Guangyong, Ratzki-Leewing, Alexandria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299942/
https://www.ncbi.nlm.nih.gov/pubmed/37270453
http://dx.doi.org/10.1007/s13300-023-01423-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299942/
https://www.ncbi.nlm.nih.gov/pubmed/37270453
http://dx.doi.org/10.1007/s13300-023-01423-3

Ejemplares similares